Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

636 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma.
Sugimoto K, Taguchi S, Kishitani K, Kawai T, Masuda K, Nakamura Y, Kinjo M, Tambo M, Miyakawa J, Akiyama Y, Yamada Y, Sato Y, Yamada D, Nakagawa T, Fukuhara H, Kume H. Sugimoto K, et al. Among authors: kume h. BMC Urol. 2022 Nov 9;22(1):177. doi: 10.1186/s12894-022-01139-9. BMC Urol. 2022. PMID: 36352389 Free PMC article.
[Bladder recurrence of renal cell carcinoma: report of two cases].
Kume H, Nyoumura S, Niimi A, Fujimura T, Fukuhara H, Ishikawa A, Nishimatsu H, Tomita K, Takeuchi T, Kitamura T. Kume H, et al. Nihon Hinyokika Gakkai Zasshi. 2007 Jul;98(5):718-22. doi: 10.5980/jpnjurol1989.98.718. Nihon Hinyokika Gakkai Zasshi. 2007. PMID: 17682452 Free article. Japanese.
WITHDRAWN: Relationships between 8q24 and 17q risk loci and sporadic or latent prostate cancer and the impacts of these loci on the clinicopathologic characteristics of prostate cancer.
Liu M, Suzuki M, Kurosaki T, Kume H, Ishikawa A, Enomoto Y, Nishimatsu H, Fukuhara H, Fujimura T, Arai T, Sawabe M, Homma Y, Kitamura T. Liu M, et al. Among authors: kume h. Biochem Biophys Res Commun. 2009 Dec 21. doi: 10.1016/j.bbrc.2009.12.071. Online ahead of print. Biochem Biophys Res Commun. 2009. PMID: 20026053
Final report on low-dose estramustine phosphate (EMP) monotherapy and very low-dose EMP therapy combined with LH-RH agonist for previously untreated advanced prostate cancer.
Kitamura T, Suzuki M, Nishimatsu H, Kurosaki T, Enomoto Y, Fukuhara H, Kume H, Takeuchi T, Miao L, Jiangang H, Xiaoqiang L. Kitamura T, et al. Among authors: kume h. Aktuelle Urol. 2010 Jan;41 Suppl 1:S34-40. doi: 10.1055/s-0029-1224657. Epub 2010 Jan 21. Aktuelle Urol. 2010. PMID: 20094950
636 results